Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies

Clinical trial NCT03638206 · UNKNOWN

Trial details

NCT number: NCT03638206
Sponsor: Shenzhen BinDeBio Ltd.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Acute Lymphoblastic Leukemia Lymphoma Myeloid Leukemia Multiple Myeloma Hepatoma Gastric Cancer Pancreatic Cancer Mesothelioma Colorectal Cancer Esophagus Cancer Lung Cancer Glioma

Start date: 2018-03-01
Primary completion: 2023-03-01
Enrollment: 73

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.